Analysis of Immune Correlates Using Anti-PD-1 Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation Therapy

被引：4
|
作者：
Kim, S. [1 ]
Sanders, P. D. [1 ]
Weihe, E. [1 ]
Purcell, T. [1 ]
Kato, S. [1 ]
Patel, S. [1 ]
Kurzrock, R. [1 ]
Sharabi, A. [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.2051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3434
引用
收藏
页码：E602 / E603
页数：2
相关论文
共 50 条
  • [31] Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
    Gide, Tuba N.
    Quek, Camelia
    Menzies, Alexander M.
    Tasker, Annie T.
    Shang, Ping
    Holst, Jeff
    Madore, Jason
    Lim, Su Yin
    Velickovic, Rebecca
    Wongchenko, Matthew
    Yan, Yibing
    Lo, Serigne
    Carlino, Matteo S.
    Guminski, Alexander
    Saw, Robyn P. M.
    Pang, Angel
    McGuire, Helen M.
    Palendira, Umaimainthan
    Thompson, John F.
    Rizos, Helen
    da Silva, Ines Pires
    Batten, Marcel
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    CANCER CELL, 2019, 35 (02) : 238 - +
  • [32] Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
    George, Suzanne
    Miao, Diana
    Demetri, George D.
    Adeegbe, Dennis
    Rodig, Scott J.
    Shukla, Sachet
    Lipschitz, Mikel
    Amin-Mansour, Ali
    Raut, Chandrajit P.
    Carter, Scott L.
    Hammerman, Peter
    Freeman, Gordon J.
    Wu, Catherine J.
    Ott, Patrick A.
    Wong, Kwok-Kin
    Van Allen, Eliezer M.
    IMMUNITY, 2017, 46 (02) : 197 - 204
  • [33] Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma
    Kif, Roberta
    Johansson, Junko
    Bagge, Roger Olofsson
    Martner, Anna
    EJSO, 2021, 47 (09): : 2460 - 2464
  • [34] Clinical Outcomes of Melanoma Brain Metastases Treated With Stereotactic Radiation and Anti-PD-1 Therapy
    Ahmed, K. A.
    Stallworth, D. G.
    Johnstone, P. A. S.
    Harrison, L. B.
    Etame, A. B.
    Weber, J. S.
    Gibney, G. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S57 - S57
  • [35] Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hurthle Cell Carcinoma: A Case Report and Literature Review
    He, Haihua
    Xu, Tangpeng
    Li, Ping
    Jia, Guohua
    Li, Xiangpan
    Song, Qibin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] CS3003, an HDAC6-selective inhibitor, improves anti-PD-1 immune checkpoint blockade therapy efficacy
    Li, Zhenhu
    Ren, Zhaoxiang
    Ma, Jingshu
    Tang, Liang
    Lu, Liang
    Zhu, Ying
    Wu, Yunfei
    Liu, Tiancheng
    Zhang, Juan
    Bao, Yuanwu
    Zhang, Kangyu
    Wei, Changqing
    Chen, Shuhui
    Wang, Xinzhong Jon
    CANCER RESEARCH, 2020, 80 (16)
  • [37] Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
    Ahmed, K. A.
    Stallworth, D. G.
    Kim, Y.
    Johnstone, P. A. S.
    Harrison, L. B.
    Caudell, J. J.
    Yu, H. H. M.
    Etame, A. B.
    Weber, J. S.
    Gibney, G. T.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 434 - 441
  • [38] Immunological Mechanisms behind Anti-PD-1/PD-L1 Immune Checkpoint Blockade: Intratumoral Reinvigoration or Systemic Induction?
    Guo, Zhikun
    Yu, Jiangnan
    Chen, Zihan
    Chen, Shuxian
    Wang, Lei
    BIOMEDICINES, 2024, 12 (04)
  • [39] Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Negative Patient With Refractory Metastatic Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review
    Zhao, Xiangrong
    Kong, Yuehong
    Zhang, Liyuan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma
    Park, Jong Chul
    Durbeck, Julia
    Boudadi, Karim
    Ho, Wen Jin
    Kang, Hyunseok
    ORAL ONCOLOGY, 2020, 108
12345